Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
Efficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed/refractory lymphoma: a prospective multi-center phase II study by the Puget Sound Oncology Consortium
Leukemia & Lymphoma (2010)
  • Ajay K. Gopal, Fred Hutchinson Cancer Research Center
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
  • Andrei R. Shustov, Fred Hutchinson Cancer Research Center
  • Stephen H. Petersdorf, Fred Hutchinson Cancer Research Center
  • Ted A. Gooley, Fred Hutchinson Cancer Research Center
  • Jasmine T. Daniels, Madigan Army Medical Center
  • Mitchell A. Garrison, Fred Hutchinson Cancer Research Center
  • George F. Gjerset, Fred Hutchinson Cancer Research Center
  • Matthew Lonergan, Fred Hutchinson Cancer Research Center
  • Anne E. Murphy, Fred Hutchinson Cancer Research Center
  • Julie C. Smith, Fred Hutchinson Cancer Research Center
  • John M. Pagel, Fred Hutchinson Cancer Research Center
Link
Disciplines
Publication Date
January 8, 2010
DOI
10.3109/10428194.2010.491137
Citation Information
Ajay K. Gopal, Oliver W. Press, Andrei R. Shustov, Stephen H. Petersdorf, et al.. "Efficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed/refractory lymphoma: a prospective multi-center phase II study by the Puget Sound Oncology Consortium" Leukemia & Lymphoma Vol. 51 Iss. 8 (2010) p. 1523 - 1529
Available at: http://works.bepress.com/john-pagel/211/